Renaissance Technologies
AMPE

Renaissance Technologies’s Ampio Pharmaceuticals Inc. AMPE Stock Holding History

Renaissance Technologies’s Portfolio AMPE Stock Details AMPE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-1,425
Closed -$7K – 4321
2023
Q2 		$7K Buy
1,425
+565
+66% +$2.77K ﹤0.01% 3844
2023
Q1 		$4K Buy
+860
New +$4.83K ﹤0.01% 3919
2022
Q3 		– Sell
-1,453
Closed -$73K – 4552
2022
Q2 		$73K Sell
1,453
-6,106
-81% -$454K ﹤0.01% 3927
2022
Q1 		$1.07M Sell
7,559
-449
-6% -$65.6K ﹤0.01% 2685
2021
Q4 		$1.37M Buy
+8,008
New +$2.99M ﹤0.01% 2430
2020
Q1 		– Sell
-476
Closed -$83K – 3935
2019
Q4 		$83K Sell
476
-108
-18% -$13.9K ﹤0.01% 3342
2019
Q3 		$88K Buy
+584
New +$77.8K ﹤0.01% 3273
2016
Q4 		– Sell
-579
Closed -$128K – 3542
2016
Q3 		$128K Buy
+579
New +$162K ﹤0.01% 3145

Other funds holding AMPE

CCMW
Cypress Capital Management (Wyoming) Sheridan, Wyoming $108M AUM 54.47% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
GIA
GHP Investment Advisors Denver, Colorado $2.72B AUM 27.58% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SS
Sunbelt Securities Houston, Texas $1.58B AUM 28.96% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
JWA
JFS Wealth Advisors Hermitage, Pennsylvania $2.01B AUM 21.74% 1-Year Est. Return
JWM
Janiczek Wealth Management Denver, Colorado $477M AUM 15.17% 1-Year Est. Return

Renaissance Technologies's AMPE Position: Q3 2023 in Review

Renaissance Technologies sold out of Ampio Pharmaceuticals Inc. (AMPE) in Q3 2023, closing a stake of 1,425 shares — an estimated $7K sold.

Renaissance Technologies first reported a position in AMPE in Q3 2016 and held it in 8 quarters. The position peaked at $1.37M in Q4 2021. 26 funds tracked by Wall St. Rank hold AMPE as of Q3 2023.

  • Renaissance Technologies reported no remaining Ampio Pharmaceuticals Inc. position as of Q3 2023 after selling out during the quarter.
  • Renaissance Technologies sold 1,425 Ampio Pharmaceuticals Inc. shares in Q3 2023, an estimated $7K.
  • Renaissance Technologies first reported a position in Ampio Pharmaceuticals Inc. in Q3 2016 and held it in 8 quarters.
  • Renaissance Technologies's Ampio Pharmaceuticals Inc. position peaked at $1.37M in Q4 2021.
  • 26 funds tracked by Wall St. Rank held Ampio Pharmaceuticals Inc. as of Q3 2023.

Based on Renaissance Technologies's 13F filing for Q3 2023, filed 14 Nov 2023.